Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Modular Platform Processes Nucleic Acids and Proteins

By Labmedica staff writers
Posted on 07 Feb 2008
A novel modular platform offers laboratories a new level of flexibility and safety in automated processing of a broad range of samples. More...


Called the QIAsymphony SP, the platform allows users to load samples in different formats, and to isolate, purify, and prepare target analytes for analysis. This step is the most challenging of any molecular analysis. QIAsymphony SP was designed to meet a labs' flexibility and workflow needs. The system can handle a large variety of starting materials and a wide range of input volumes. More than 40 protocols to process DNA, RNA, and proteins have been optimized for use on the platform.

QIAsymphony SP is the first system in Qiagen's (Frankfurt, Germany) new series of modular instruments that can be integrated to automate entire workflows. The novel platform is the result of the largest development program ever undertaken at Qiagen.

The system incorporates many new features such as processing continuous sample racks, reagents, and consumables, and has the ability to perform several purification procedures on one batch of samples by reloading reagents. The system has a wide bandwidth of throughput settings, from a few a day to several hundred. The most complicated processes can be operated by a novice and there is no need retrain laboratory staff. Convenient touch screen operations and bar codes allow easy tracking of reagents, guaranteeing maximum safety and reproducible results.

QIAsymphony SP received the New Product Award (NPA) Designation of the Association for Laboratory Automation (ALA; Geneva, IL, USA). The award was presented to Qiagen on January 29, 2008, at LabAutomation in Palm Springs, CA (USA); an international conference and exhibit for laboratory technologies, where QIAsymphony SP was officially launched on January 28.



Related Links:
Qiagen
Association for Laboratory Automation

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.